Pharmacological Activation of hERG Potassium Channels in Congenital Long QT Syndrome 2 Activator Compound ICA105574 and its Effects on Mutant hERG Potassium Channels in Long QT Syndrome 2
2018
-
Heart, Lung and Circulation
Home
/
Platform
/
Publications
/
Pharmacological Activation of hERG Potassium Channels in Congenital Long QT Syndrome 2 Activator Compound ICA105574 and its Effects on Mutant hERG Potassium Channels in Long QT Syndrome 2
